Hallux Valgus Market

DelveInsight's "Hallux Valgus Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Hallux Valgus , historical and forecasted epidemiology as well as the Hallux Valgus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.


The Hallux Valgus market report provides current treatment practices, emerging drugs, Hallux Valgus market share of the individual therapies, current and forecasted Hallux Valgus market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current Hallux Valgus treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.

Geography Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2017-2030

Hallux Valgus Disease Understanding and Treatment Algorithm

The DelveInsight Hallux Valgus market report gives a thorough understanding of the Hallux Valgus by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis and treatment. 


Diagnosis 

This segment of the report covers the detailed diagnostic methods or tests for Hallux Valgus . 


Treatment 

It covers the details of conventional and current medical therapies available in the Hallux Valgus market for the treatment of the condition. It also provides Hallux Valgus treatment algorithms and guidelines in the United States, Europe, and Japan. 

Hallux Valgus Epidemiology  

The Hallux Valgus epidemiology division provide insights about historical and current Hallux Valgus patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.  


Key Findings

The disease epidemiology covered in the report provides historical as well as forecasted Hallux Valgus epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030. 


Country Wise- Hallux Valgus Epidemiology 

The epidemiology segment also provides the Hallux Valgus epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. 

Hallux Valgus Drug Chapters

Drug chapter segment of the Hallux Valgus report encloses the detailed analysis of Hallux Valgus marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. It also helps to understand the Hallux Valgus clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.


Marketed Drugs 

The report provides the details of the marketed product available for Hallux Valgus treatment. 


Hallux Valgus Emerging Drugs 

The report provides the details of the emerging therapies under the late and mid-stage of development for Hallux Valgus treatment. 

Hallux Valgus Market Outlook

The Hallux Valgus market outlook of the report helps to build the detailed comprehension of the historic, current, and forecasted Hallux Valgus market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology. 


This segment gives a thorough detail of Hallux Valgus market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria's, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight. 


According to DelveInsight, Hallux Valgus market in 7MM is expected to change in the study period 2017-2030.


Key Findings

This section includes a glimpse of the Hallux Valgus market in 7MM.


The United States Market Outlook

This section provides the total Hallux Valgus market size and market size by therapies in the United States.


EU-5 Countries: Market Outlook

The total Hallux Valgus market size and market size by therapies in Germany, France, Italy, Spain, and the United Kingdom is provided in this section.


Japan Market Outlook 

The total Hallux Valgus market size and market size by therapies in Japan is also mentioned. 

Hallux Valgus Drugs Uptake

This section focusses on the rate of uptake of the potential drugs recently launched in the Hallux Valgus market or expected to get launched in the market during the study period 2017-2030. The analysis covers Hallux Valgus market uptake by drugs; patient uptake by therapies; and sales of each drug.    


This helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Hallux Valgus Pipeline Development Activities 

The report provides insights into different therapeutic candidates in Phase II, and Phase III stage. It also analyses Hallux Valgus key players involved in developing targeted therapeutics. 


Pipeline Development Activities

The report covers the detailed information of collaborations, acquisition and merger, licensing, patent details and other information for Hallux Valgus emerging therapies.

Reimbursement Scenario in Hallux Valgus

Approaching reimbursement proactively can have a positive impact both during the late stages of product development and well after product launch. In a report, we take reimbursement into consideration to identify economically attractive indications and market opportunities. When working with finite resources, the ability to select the markets with the fewest reimbursement barriers can be a critical business and price strategy. 

KOL- Views 

To keep up with current market trends, we take KOLs and SME's opinion working in Hallux Valgus domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Hallux Valgus market trend. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the market and the unmet needs. 

Competitive Intelligence Analysis 

We perform Competitive and Market Intelligence analysis of the Hallux Valgus Market by using various Competitive Intelligence tools that include - SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies etc. The inclusion of the analysis entirely depends upon the data availability.

Scope of the Report

  • The report covers the descriptive overview of Hallux Valgus , explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
  • Comprehensive insight has been provided into the Hallux Valgus epidemiology and treatment in the 7MM
  • Additionally, an all-inclusive account of both the current and emerging therapies for Hallux Valgus are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
  • A detailed review of Hallux Valgus market; historical and forecasted is included in the report, covering drug outreach in the 7MM
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Hallux Valgus market

Report Highlights

  • In the coming years, Hallux Valgus market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market
  • The companies and academics are working to assess challenges and seek opportunities that could influence Hallux Valgus R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition       
  • Major players are involved in developing therapies for Hallux Valgus . Launch of emerging therapies will significantly impact the Hallux Valgus market
  • A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Hallux Valgus
  • Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities


Hallux Valgus Report Insights

  • Patient Population
  • Therapeutic Approaches
  • Hallux Valgus Pipeline Analysis
  • Hallux Valgus Market Size and Trends
  • Market Opportunities
  • Impact of upcoming Therapies


Hallux Valgus Report Key Strengths

  • 11 Years Forecast
  • 7MM Coverage 
  • Hallux Valgus Epidemiology Segmentation
  • Key Cross Competition 
  • Highly Analyzed Market
  • Drugs Uptake


Hallux Valgus Report Assessment

  • Current Treatment Practices
  • Unmet Needs
  • Pipeline Product Profiles
  • Market Attractiveness
  • Market Drivers and Barriers

Key Questions

Market Insights:

  • What was the Hallux Valgus market share (%) distribution in 2017 and how it would look like in 2030?
  • What would be the Hallux Valgus total market size as well as market size by therapies across the 7MM during the forecast period (2017-2030)?
  • What are the key findings pertaining to the market across 7MM and which country will have the largest Hallux Valgus market size during the forecast period (2017-2030)?
  • At what CAGR, the Hallux Valgus market is expected to grow in 7MM during the forecast period (2017-2030)?
  • What would be the Hallux Valgus market outlook across the 7MM during the forecast period (2017-2030)?
  • What would be the Hallux Valgus market growth till 2030, and what will be the resultant market Size in the year 2030?
  • How would the market drivers, barriers and future opportunities affect the market dynamics and subsequent analysis of the associated trends?


Epidemiology Insights:

  • What is the disease risk, burden and unmet needs of the Hallux Valgus ?
  • What is the historical Hallux Valgus patient pool in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
  • What would be the forecasted patient pool of Hallux Valgus in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
  • What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Hallux Valgus ?
  • Out of all 7MM countries, which country would have the highest prevalent population of Hallux Valgus during the forecast period (2017-2030)?
  • At what CAGR the population is expected to grow in 7MM during the forecast period (2017-2030)?

Current Treatment Scenario, Marketed Drugs and Emerging Therapies:

  • What are the current options for the Hallux Valgus treatment, along with the approved therapy?
  • What are the current treatment guidelines for the treatment of Hallux Valgus in the USA, Europe, and Japan?
  • What are the Hallux Valgus marketed drugs and their MOA, regulatory milestones, product development activities, advantages, disadvantages, safety and efficacy, etc.?
  • How many companies are developing therapies for the treatment of Hallux Valgus ?
  • How many therapies are developed by each company for Hallux Valgus treatment?
  • How many are emerging therapies in mid-stage, and late stage of development for Hallux Valgus treatment?
  • What are the key collaborations (Industry - Industry, Industry - Academia), Mergers and acquisitions, licensing activities related to the Hallux Valgus therapies? 
  • What are the recent novel therapies, targets, mechanisms of action and technologies developed to overcome the limitation of existing therapies? 
  • What are the clinical studies going on for Hallux Valgus and their status?
  • What are the key designations that have been granted for the emerging therapies for Hallux Valgus ?
  • What are the global historical and forecasted market of Hallux Valgus ?

Reasons to buy

  • The report will help in developing business strategies by understanding trends shaping and driving the Hallux Valgus market
  • To understand the future market competition in the Hallux Valgus market and Insightful review of the key market drivers and barriers
  • Organize sales and marketing efforts by identifying the best opportunities for Hallux Valgus in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
  • Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
  • Organize sales and marketing efforts by identifying the best opportunities for Hallux Valgus market
  • To understand the future market competition in the Hallux Valgus market

1. Key Insights

2. Executive Summary of Hallux Valgus

3. SWOT Analysis

4. Epidemiology and Market Forecast Flow

5. Hallux Valgus: Market Share (%) Distribution Overview at a Glance: By Country

6. Hallux Valgus: Disease Background and Overview

6.1. Introduction

6.2. Types of Bunions

6.3. Classification of Bunions

6.4. Causes

6.5. Risk Factors

6.6. Signs and Symptoms

6.7. Pathophysiology

6.8. Diagnosis

6.8.1. Imaging Tests

6.8.2. Laboratory Tests

6.9. Diagnostic Algorithm

6.10. Diagnostic Guidelines

6.10.1. British Orthopedic Guidelines

6.10.2. Map of medicine health guides (Sheffield)

7. Epidemiology and Patient Population

7.1. Epidemiology Key Findings

7.2. Assumptions and Rationale

7.3. Epidemiology Scenario: 7MM

7.3.1. Total Prevalent Cases of Hallux Valgus by Age in the 7MM

7.3.2. Total Diagnosed Prevalent Cases of Hallux Valgus in the 7MM

7.3.3. Gender-specific Prevalent Cases of Hallux Valgus in the 7MM

7.3.4. Severity-specific Prevalent Cases of Hallux Valgus in the 7MM

7.3.5. Treated cases of Hallux Valgus in the 7MM

7.4. The United States Epidemiology

7.4.1. Total Prevalent Cases of Hallux Valgus by Age in the United States

7.4.2. Total Diagnosed Prevalent Cases of Hallux Valgus in the United States

7.4.3. Gender-specific Prevalent Cases of Hallux Valgus in the United States

7.4.4. Severity-specific Prevalent Cases of Hallux Valgus in the United States

7.4.5. Treated cases of Hallux Valgus in the United States

7.5. EU-5 Epidemiology

7.6. Germany

7.6.1. Total Prevalent Cases of Hallux Valgus by Age in Germany

7.6.2. Total Diagnosed Prevalent Cases of Hallux Valgus in Germany

7.6.3. Gender-specific Prevalent Cases of Hallux Valgus in Germany

7.6.4. Severity-specific Prevalent Cases of Hallux Valgus in Germany

7.6.5. Treated cases of Hallux Valgus in Germany

7.7. France

7.7.1. Total Prevalent Cases of Hallux Valgus by Age in France

7.7.2. Total Diagnosed Prevalent Cases of Hallux Valgus in France

7.7.3. Gender-specific Prevalent Cases of Hallux Valgus in France

7.7.4. Severity-specific Prevalent Cases of Hallux Valgus in France

7.7.5. Treated cases of Hallux Valgus in France

7.8. Italy

7.8.1. Total Prevalent Cases of Hallux Valgus by Age in Italy

7.8.2. Total Diagnosed Prevalent Cases of Hallux Valgus in Italy

7.8.3. Gender-specific Prevalent Cases of Hallux Valgus in Italy

7.8.4. Severity-specific Prevalent Cases of Hallux Valgus in Italy

7.8.5. Treated cases of Hallux Valgus in Italy

7.9. Spain

7.9.1. Total Prevalent Cases of Hallux Valgus by Age in Spain

7.9.2. Total Diagnosed Prevalent Cases of Hallux Valgus in Spain

7.9.3. Gender-specific Prevalent Cases of Hallux Valgus in Spain

7.9.4. Severity-specific Prevalent Cases of Hallux Valgus in Spain

7.9.5. Treated cases of Hallux Valgus in Spain

7.10. The United Kingdom

7.10.1. Total Prevalent Cases of Hallux Valgus by Age in the United Kingdom

7.10.2. Total Diagnosed Prevalent Cases of Hallux Valgus in the United Kingdom

7.10.3. Gender-specific Prevalent Cases of Hallux Valgus in the United Kingdom

7.10.4. Severity-specific Prevalent Cases of Hallux Valgus in the United Kingdom

7.10.5. Treated cases of Hallux Valgus in the United Kingdom

7.11. Japan Epidemiology

7.11.1. Total Prevalent Cases of Hallux Valgus by Age in Japan

7.11.2. Total Diagnosed Prevalent Cases of Hallux Valgus in Japan

7.11.3. Gender-specific Prevalent Cases of Hallux Valgus in Japan

7.11.4. Severity-specific Prevalent Cases of Hallux Valgus in Japan

7.11.5. Treated cases of Hallux Valgus in Japan

8. Current Treatment Practices

8.1. Treatment Algorithm

8.2. Conservative Treatment

8.3. Surgery

8.3.1. Devices

8.3.2. Post-surgery

8.4. Journal of Orthopedic & Sports Physical Therapy

8.5. American Podiatric Medical Association (APMA)

8.6. National Health Service (NHS)

8.7. Physical Therapy Guidelines for Hallux Valgus Correction (Bunion Reconstruction)

8.8. British Orthopedic Association

9. Unmet Needs

10. Patient Journey

11. Key Endpoints in Hallux Valgus Clinical Trials

12. Marketed Products

12.1. Magnezix CS: Syntellix

12.1.1. Product Description

12.1.2. Regulatory Milestones

12.1.3. Other Developmental Activities

12.2. Lapiplasty 3-Dimensional Bunion Correction: Treace Medical Concepts

12.2.1. Product Description

12.3. Regulatory Milestones

12.3.1. Other Developmental Activities

12.3.2. Pivotal Clinical Trial

12.3.3. Ongoing Current Pipeline Activity

12.4. PROstep Minimally Invasive Surgery System: Wright Medical Technology

12.4.1. Product Description

12.4.2. Regulatory Milestones

12.4.3. Pivotal Clinical Trial

12.5. Minimally Invasive Bunion (M.I.B.) Plating System: Trilliant Surgical

12.5.1. Product Description

12.5.2. Regulatory Milestones

12.5.3. Pivotal Clinical Trial

12.6. KISSloc Suture System: Arthrosurface

12.6.1. Product Description

12.6.2. Regulatory Milestones

12.7. Axi+Line Proximal Bunion Correction System: Nextremity Solutions

12.7.1. Product Description

12.7.2. Regulatory Milestones

12.7.3. Other Developmental Activities

12.7.4. Pivotal Clinical Trial Summary

12.8. Cartiva Synthetic Cartilage Implant (CARTIVA SCI)-Wright medical

12.8.1. Product Description

12.8.2. Regulatory Milestones

12.8.3. Other Developmental Activities

12.8.4. Pivotal Clinical Trial

13. Hallux Valgus: Seven Major Market Analysis

13.1. Key Findings

13.2. 7MM Market Size

13.2.1. Total Market Size of Hallux Valgus in the 7MM

13.2.2. Total Market size of Hallux Valgus by Treatment Options in the 7MM

13.3. United States Market Size

13.3.1. Total Market size of Hallux Valgus in the United States

13.4. EU-5 Market Size

13.5. Germany Market Size

13.5.1. Total Market size of Hallux Valgus in Germany

13.6. France Market Size

13.6.1. Total Market size of Hallux Valgus in France

13.7. Italy Market Size

13.7.1. Total Market size of Hallux Valgus in Italy

13.8. Spain Market Size

13.8.1. Total Market size of Hallux Valgus in Spain

13.9. United Kingdom Market Size

13.9.1. Total Market size of Hallux Valgus in the United Kingdom

13.10. Japan Market Size

13.10.1. Total Market size of Hallux Valgus in Japan

14. Market Access and Reimbursement

15. Market Drivers

16. Market Barriers

17. Appendix

17.1. Bibliography

17.2. Report Methodology

17.3. DelveInsight Capabilities

18. Disclaimer

19. About DelveInsight

List of Tables

Table 1 Summary of Hallux Valgus, Market, Epidemiology, and Key Events (2017–2030)

Table 2 Degree Hallux valgus angle (HVA) / Intermetatarsal angle (IMA)

Table 3 Assessment

Table 4 Consider differential diagnoses

Table 5 History and examinations

Table 6 Radiographic Response

Table 7 Typical Presenting Features

Table 8 Assess severity from signs and symptoms

Table 9 Total Prevalent Cases of Hallux Valgus in the 7MM (2017–2030)

Table 10 Total Prevalent Cases of Hallux Valgus by Age in the 7MM (2017–2030)

Table 11 Total Diagnosed cases of Hallux Valgus in the 7MM (2017–2030)

Table 12 Gender-specific Prevalent Cases of Hallux Valgus in the 7MM (2017–2030)

Table 13 Severity-specific Prevalent Cases of Hallux Valgus in the 7MM (2017–2030)

Table 14 Total Treated cases of Hallux Valgus in the 7MM (2017–2030)

Table 15 Total Prevalent Cases of Hallux Valgus by Age in the United States (2017–2030)

Table 16 Total Diagnosed Prevalent Cases of Hallux Valgus in the United States (2017–2030)

Table 17 Gender-specific Prevalent Cases of Hallux Valgus in the United States (2017–2030)

Table 18 Severity-specific Prevalent Cases of Hallux Valgus in the United States (2017–2030)

Table 19 Total Treated cases of Hallux Valgus in the United States (2017–2030)

Table 20 Total Prevalent Cases of Hallux Valgus by Age in Germany (2017–2030)

Table 21 Total Diagnosed Prevalent Cases of Hallux Valgus in Germany (2017–2030)

Table 22 Gender-specific Prevalent Cases of Hallux Valgus in Germany (2017–2030)

Table 23 Severity-specific Prevalent Cases of Hallux Valgus in Germany (2017–2030)

Table 24 Total Treated cases of Hallux Valgus in Germany (2017–2030)

Table 25 Total Prevalent Cases of Hallux Valgus by Age in France (2017–2030)

Table 26 Total Diagnosed Prevalent Cases of Hallux Valgus in France (2017–2030)

Table 27 Gender-specific Prevalent Cases of Hallux Valgus in France (2017–2030)

Table 28 Severity-specific Prevalent Cases of Hallux Valgus in France (2017–2030)

Table 29 Total Treated cases of Hallux Valgus in France (2017–2030)

Table 30 Total Prevalent Cases of Hallux Valgus by Age in Italy (2017–2030)

Table 31 Total Diagnosed Prevalent Cases of Hallux Valgus in Italy (2017–2030)

Table 32 Gender-specific Prevalent Cases of Hallux Valgus in Italy (2017–2030)

Table 33 Severity-specific Prevalent Cases of Hallux Valgus in Italy (2017–2030)

Table 34 Total Treated cases of Hallux Valgus in Italy (2017–2030)

Table 35 Total Prevalent Cases of Hallux Valgus by Age in Spain (2017–2030)

Table 36 Total Diagnosed Prevalent Cases of Hallux Valgus in Spain (2017–2030)

Table 37 Gender-specific Prevalent Cases of Hallux Valgus in Spain (2017–2030)

Table 38 Severity-specific Prevalent Cases of Hallux Valgus in Spain (2017–2030)

Table 39 Total Treated cases of Hallux Valgus in Spain (2017–2030)

Table 40 Total Prevalent Cases of Hallux Valgus by Age in the United Kingdom (2017–2030)

Table 41 Total Diagnosed Prevalent Cases of Hallux Valgus in the United Kingdom (2017–2030)

Table 42 Gender-specific Prevalent Cases of hallux valgus in the United Kingdom (2017–2030)

Table 43 Severity-specific Prevalent Cases of Hallux Valgus in the United Kingdom (2017–2030)

Table 44 Total Treated cases of Hallux Valgus in the United Kingdom (2017–2030)

Table 45 Total Prevalent Cases of Hallux Valgus by Age in Japan (2017–2030)

Table 46 Total Diagnosed Prevalent Cases of Hallux Valgus in Japan (2017–2030)

Table 47 Gender-specific Prevalent Cases of Hallux Valgus in Japan (2017–2030)

Table 48 Severity-specific Prevalent Cases of Hallux Valgus in Japan (2017–2030)

Table 49 Total Treated cases of Hallux Valgus in Japan (2017–2030)

Table 50 Different types of bunions based on their severity

Table 51 Physical Therapy Guidelines for Hallux Valgus

Table 52 Summary of Pivotal Trial

Table 53 Lapiplasty 3-Dimensional Bunion Correction, Clinical Trial Description, 2020

Table 54 7MM Market Size of Hallux Valgus, in USD Million (2017–2030)

Table 55 7MM Market Size of Hallux Valgus by Treatment Options, in USD Million (2017–2030)

Table 56 Total United States Market Size of Hallux Valgus, in USD Million (2017–2030)

Table 57 United States Market Size of Hallux Valgus by Treatment Options, in USD Million (2017–2030)

Table 58 Germany Market Size of Hallux Valgus, in USD Million (2017–2030)

Table 59 Germany Market Size of Hallux Valgus by Treatment Options, in USD Million (2017–2030)

Table 60 France Market Size of Hallux Valgus, in USD Million (2017–2030)

Table 61 France Market Size of Hallux Valgus by Treatment Options, in USD Million (2017–2030)

Table 62 Italy Market Size of Hallux Valgus, in USD Million (2017–2030)

Table 63 Italy Market Size of Hallux Valgus by Treatment Options, in USD Million (2017–2030)

Table 64 Spain Market Size of Hallux Valgus, in USD Million (2017–2030)

Table 65 Spain Market Size of Hallux Valgus by Treatment Options, in USD Million (2017–2030)

Table 66 United Kingdom Market Size of Hallux Valgus, in USD Million (2017–2030)

Table 67 United Kingdom Market Size of Hallux Valgus by Treatment Options, in USD Million (2017–2030)

Table 68 Japan Market Size of Hallux Valgus, in USD Million (2017–2030)

Table 69 Japan Market Size of Hallux Valgus by Treatment Options, in USD Million (2017–2030)

Table 70 How Medicare Can Help Pay for Bunion Surgery

Table 71 Lower Extremity 2020 Reimbursement Guide

List of Figures

Figure 1 Hallux Valgus SWOT Analysis

Figure 2 Anatomy of the Normal toe and Bunion

Figure 3 Types of Bunions

Figure 4 General classification of Bunions

Figure 5 Signs and Symptoms

Figure 6 Diagnostic Algorithm

Figure 7 Total Prevalent Cases of Hallux Valgus in the 7MM (2017–2030)

Figure 8 Total Prevalent Cases of Hallux Valgus by Age in the 7MM (2017–2030)

Figure 9 Total Diagnosed Prevalent Cases of Hallux Valgus in the 7MM (2017–2030)

Figure 10 Gender-specific Prevalent Cases of Hallux Valgus in the 7MM (2017–2030)

Figure 11 Severity-specific Prevalent Cases of Hallux Valgus in the 7MM (2017–2030)

Figure 12 Total Treated cases of Hallux Valgus in the 7MM (2017–2030)

Figure 13 Total Prevalent Cases of Hallux Valgus by Age in the United States (2017–2030)

Figure 14 Total Diagnosed Prevalent Cases of Hallux Valgus in the United States (2017–2030)

Figure 15 Gender-specific Prevalent Cases of Hallux Valgus in the United States (2017–2030)

Figure 16 Severity-specific Prevalent Cases of Hallux Valgus in the United States (2017–2030)

Figure 17 Treated cases of Hallux Valgus in the United States (2017–2030)

Figure 18 Total Prevalent Cases of Hallux Valgus by Age in Germany (2017–2030)

Figure 19 Total Diagnosed Prevalent Cases of Hallux Valgus in Germany (2017–2030)

Figure 20 Gender-specific Prevalent Cases of Hallux Valgus in Germany (2017–2030)

Figure 21 Severity-specific Prevalent Cases of Hallux Valgus in Germany (2017–2030)

Figure 22 Treated cases of Hallux Valgus in Germany (2017–2030)

Figure 23 Total Prevalent Cases of Hallux Valgus by Age in France (2017–2030)

Figure 24 Total Diagnosed Prevalent Cases of Hallux Valgus in France (2017–2030)

Figure 25 Gender-specific Prevalent Cases of Hallux Valgus in France (2017–2030)

Figure 26 Severity-specific Prevalent Cases of Hallux Valgus in France (2017–2030)

Figure 27 Treated cases of Hallux Valgus in France (2017–2030)

Figure 28 Total Prevalent Cases of Hallux Valgus by Age in Italy (2017–2030)

Figure 29 Total Diagnosed Prevalent Cases of Hallux Valgus in Italy (2017–2030)

Figure 30 Gender-specific Prevalent Cases of Hallux Valgus in Italy (2017–2030)

Figure 31 Severity-specific Prevalent Cases of Hallux Valgus in Italy (2017–2030)

Figure 32 Treated cases of Hallux Valgus in Italy (2017–2030)

Figure 33 Total Prevalent Cases of Hallux Valgus by Age in Spain (2017–2030)

Figure 34 Total Diagnosed Prevalent Cases of Hallux Valgus in Spain (2017–2030)

Figure 35 Gender-specific Prevalent Cases of Hallux Valgus in Spain (2017–2030)

Figure 36 Severity-specific Prevalent Cases of Hallux Valgus in Spain (2017–2030)

Figure 37 Treated cases of Hallux Valgus in Spain (2017–2030)

Figure 38 Total Prevalent Cases of Hallux Valgus by Age in the United Kingdom (2017–2030)

Figure 39 Total Diagnosed Prevalent Cases of Hallux Valgus in the United Kingdom (2017–2030)

Figure 40 Gender-specific Prevalent Cases of Hallux Valgus in the United Kingdom (2017–2030)

Figure 41 Severity-specific Prevalent Cases of Hallux Valgus in the United Kingdom (2017–2030)

Figure 42 Treated cases of Hallux Valgus in the United Kingdom (2017–2030)

Figure 43 Total Prevalent Cases of Hallux Valgus by Age in Japan (2017–2030)

Figure 44 Total Diagnosed Prevalent Cases of Hallux Valgus in Japan (2017–2030)

Figure 45 Gender-specific Prevalent Cases of Hallux Valgus in Japan (2017–2030)

Figure 46 Severity-specific Prevalent Cases of Hallux Valgus in Japan (2017–2030)

Figure 47 Treated cases of Hallux Valgus in Japan (2017–2030)

Figure 48 Treatment options

Figure 49 Treatment options

Figure 50 Treatment options

Figure 51 Conservative Treatment

Figure 52 (A) Bunion Splints (B) Bunion Sleeves (C) Toe separators (D) Shoe Pads

Figure 53 Types of Surgery

Figure 54 Lapiplasty 3D Bunion Correction System

Figure 55 (A) Short-foot exercise; (B) toe-spread-out exercise; (C) heel-raise exercise.

Figure 56 Unmet Needs

Figure 57 Patient Journey

Figure 58 Lapiplasty 3-Dimensional Bunion Correction

Figure 59 PROstep Instruments and Screws for Minimally-Invasive Surgery

Figure 60 PROstep MIS Bunionette Implant Construct

Figure 61 Minimally Invasive Bunion (M.I.B.) Plating System

Figure 62 KISSloc Suture System

Figure 63 Axi+Line Proximal Bunion Correction System

Figure 64 Market Size of Hallux Valgus in the 7MM, in USD Million (2017–2030)

Figure 65 Market Size of Hallux Valgus in the 7MM by Treatment Options, in USD Million (2017–2030)

Figure 66 Total Market Size of Hallux Valgus in the United States, in USD Million (2017–2030)

Figure 67 Market Size of Hallux Valgus in the United States by Treatment Options, in USD Million (2017–2030)

Figure 68 Total Market Size of Hallux Valgus in Germany, in USD Million (2017–2030)

Figure 69 Market Size of Hallux Valgus in Germany by Treatment Options, in USD Million (2017–2030)

Figure 70 Total Market Size of Hallux Valgus in France, in USD Million (2017–2030)

Figure 71 Market Size of Hallux Valgus in France by Treatment Options, in USD Million (2017–2030)

Figure 72 Total Market Size of Hallux Valgus in Italy, in USD Million (2017–2030)

Figure 73 Market Size of Hallux Valgus in Italy by Treatment Options, in USD Million (2017–2030)

Figure 74 Total Market Size of Hallux Valgus in Spain, in USD Million (2017–2030)

Figure 75 Market Size of Hallux Valgus in Spain by Treatment Options, in USD Million (2017–2030)

Figure 76 Total Market Size of Hallux Valgus in the United Kingdom, in USD Million (2017–2030)

Figure 77 Market Size of Hallux Valgus in the United Kingdom by Treatment Options, in USD Million (2017–2030)

Figure 78 Total Market Size of Hallux Valgus in Japan, in USD Million (2017–2030)

Figure 79 Market Size of Hallux Valgus in Japan by Treatment Options, in USD Million (2017–2030)

Figure 80 Market Drivers

Figure 81 Market Barriers

Syntellix

Treace Medical Concepts

Wright Medical Technology

Trilliant Surgical

Arthrosurface

Nextremity Solutions

Wright medical

  • Tags:
  • Hallux Valgus market
  • Hallux Valgus market research
  • Hallux Valgus market insight
  • Hallux Valgus market trends
  • Hallux Valgus market forecast
  • Hallux Valgus market share
  • Hallux Valgus pipeline drugs
  • Hallux Valgus treatment algorithm
  • Hallux Valgus drugs
  • Hallux Valgus sales forecasting
  • Hallux Valgus market size
  • Hallux Valgus disease
  • Hallux Valgus epidemiology
  • Hallux Valgus

Forward to Friend

Need A Quote